Updated:
Celator Pharmaceuticals Inc
Celator Pharmaceuticals Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001327467, and its reported...
Overview
Celator Pharmaceuticals Inc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001327467, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-03-21, it reported net income of USD -19,315,348; total assets of USD 25,635,184 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Celator Pharmaceuticals Inc
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Princeton, NJ, United States
- Fiscal year end
- December 31
- SEC CIK
- 0001327467
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents |
|---|---|---|---|---|
| FY2015USD | -$19.3M | $25.6M | $23.3M | |
| FY2014USD | -$16.9M | $35.1M | $32.4M | |
| FY2013USD | -$20.8M | $27.5M | $23.6M |
FY2015. Total assets: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| DEF 14A | DEF 14A | ||
| 8-K | FORM 8-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-K | 10-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Celator Pharmaceuticals Inc in Altss
Track this company’s investors, transactions and relationships in Altss.